|
1）Nathan DM, Kuenen J, Borg R, et al; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008; 31: 1473-8
|
|
|
|
2）Del Prato S. In search of normoglycaemia in diabetes: controlling postprandial glucose. Int J Obes Relat Metab Disord. 2002; 26 Suppl 3: S9-17
|
|
|
|
|
|
3）http://www.info.pmda.go.jp/downfiles/md/PDF/530366_22300BZX00435000_A_01_01.pdf
|
|
|
|
|
|
4）Ando K, Nishimura R, Tsujino D, et al. 24-hour glycemic variations in drug-naive patients with type 2 diabetes: a continuous glucose monitoring (CGM)-based study. ProS One. 2013; 8: e71102
|
|
|
|
|
|
5）Horner B, Chase H. Continuous Glucose Monitoring, The Third Era of Diabetes Manegement. Practical Diabetology. 2007; 3: 30-42
|
|
|
|
|
|
6）Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359: 1464-76
|
|
|
|
|
|
7）Bergenstal RM, Tamborlane WV, Ahmann A, et al; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363: 311-20
|
|
|
|
|
|
8）Bergenstal RM, Klonoff DC, Garg SK, et al; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013; 369: 224-32
|
|
|
|
|
|
9）Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014; 371: 313-25
|
|
|
|
|